Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broxmeyer, H. E.
Right arrow Articles by Cerami, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broxmeyer, H. E.
Right arrow Articles by Cerami, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells

HE Broxmeyer, B Sherry, L Lu, S Cooper, KO Oh, P Tekamp-Olson, BS Kwon and A Cerami

Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis.

Purified recombinant (r) macrophage inflammatory proteins (MIPs) 1 alpha, 1 beta, and 2 were assessed for effects on murine (mu) and human (hu) marrow colony-forming unit-granulocyte-macrophage (CFU-GM) and burst-forming unit-erythroid (BFU-E) colonies. Recombinant MIP-1 alpha, -1 beta, and -2 enhanced muCFU-GM colonies above that stimulated with 10 to 100 U natural mu macrophage-colony-stimulating factor (M-CSF) or rmuGM-CSF, with enhancement seen on huCFU-GM colony formation stimulated with suboptimal rhuM-CSF or rhuGM-CSF; effects were neutralized by respective MIP-specific antibodies. Macrophage inflammatory proteins had no effects on mu or huBFU-E colonies stimulated with erythropoietin (Epo). However, natural MIP-1 and rMIP-1 alpha, but not rMIP-1 beta or -2, suppressed muCFU-GM stimulated with pokeweed mitogen spleen-conditioned medium (PWMSCM), huCFU-GM stimulated with optimal rhuGM-CSF plus rhu interleukin-3 (IL-3), muBFU- E and multipotential progenitors (CFU-GEMM) stimulated with Epo plus PWMSCM, and huBFU-E and CFU-GEMM stimulated with Epo plus rhuIL-3 or rhuGM-CSF. The suppressive effects of natural MIP-1 and rMIP-1 alpha were also apparent on a population of BFU-E, CFU-GEMM, and CFU-GM present in cell-sorted fractions of human bone marrow (CD34 HLA-DR+) highly enriched for progenitors with cloning efficiencies of 42% to 75%. These results, along with our previous studies, suggest that MIP-1 alpha, -1 beta, and -2 may have direct myelopoietic enhancing activity for mature progenitors, while MIP-1 alpha may have direct suppressing activity for more immature progenitors.

Volume 76, Issue 6, pp. 1110-1116, 09/15/1990
Copyright © 1990 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
M. Iwata, M. Pillai, A. Ramakrishnan, R. C. Hackman, H. J. Deeg, G. Opdenakker, and B. Torok-Storb
Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity
Blood, January 1, 2007; 109(1): 85 - 92.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Wimmer, S. K. Khaldoyanidi, M. Judex, N. Serobyan, R. G. DiScipio, and I. U. Schraufstatter
CCL18/PARC stimulates hematopoiesis in long-term bone marrow cultures indirectly through its effect on monocytes
Blood, December 1, 2006; 108(12): 3722 - 3729.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Ottersbach, J. Mclean, N. W. Isaacs, and G. J. Graham
A310 helical turn is essential for the proliferation-inhibiting properties of macrophage inflammatory protein-1 alpha (CCL3)
Blood, February 15, 2006; 107(4): 1284 - 1291.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Hadjur and F. R. Jirik
Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines
Blood, May 15, 2003; 101(10): 3877 - 3884.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Lamkhioued, S. G. Abdelilah, Q. Hamid, N. Mansour, G. Delespesse, and P. M. Renzi
The CCR3 Receptor Is Involved in Eosinophil Differentiation and Is Up-Regulated by Th2 Cytokines in CD34+ Progenitor Cells
J. Immunol., January 1, 2003; 170(1): 537 - 547.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. K. Lee, E. H. Lee, Y. P. Yun, K. Kim, K. Kwack, D. S. Na, B. S. Kwon, and C.-K. Lee
Truncation of NH2-terminal Amino Acid Residues Increases Agonistic Potency of Leukotactin-1 on CC Chemokine Receptors 1 and 3
J. Biol. Chem., April 19, 2002; 277(17): 14757 - 14763.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Cashman, I. Clark-Lewis, A. Eaves, and C. Eaves
Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice
Blood, February 1, 2002; 99(3): 792 - 799.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
K. C. Anderson, J. D. Shaughnessy Jr., B. Barlogie, J.-L. Harousseau, and G. D. Roodman
Multiple Myeloma
Hematology, January 1, 2002; 2002(1): 214 - 240.
[Abstract] [Full Text]


Home page
BloodHome page
K. Ottersbach, D. N. Cook, W. A. Kuziel, A. Humbles, B. Lu, C. Gerard, A. E. I. Proudfoot, and G. J. Graham
Macrophage inflammatory protein-1alpha uses a novel receptor for primitive hemopoietic cell inhibition
Blood, December 1, 2001; 98(12): 3476 - 3478.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M Nazareth, P Fanti, C Schwach, K Poppenberg, K Janis, and S M Aronica
Altered Bax expression and decreased apoptosis in bone marrow cells of lupus-susceptible NZB/W mice
Lupus, November 1, 2001; 10(11): 785 - 793.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
D. M. Lindell, T. J. Standiford, P. Mancuso, Z. J. Leshen, and G. B. Huffnagle
Macrophage Inflammatory Protein 1{alpha}/CCL3 Is Required for Clearance of an Acute Klebsiella pneumoniae Pulmonary Infection
Infect. Immun., October 1, 2001; 69(10): 6364 - 6369.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. A. de Wynter, C. M. Heyworth, N. Mukaida, E. Jaworska, A. Weffort-Santos, K. Matushima, and N. G. Testa
CCR1 chemokine receptor expression isolates erythroid from granulocyte-macrophage progenitors
J. Leukoc. Biol., September 1, 2001; 70(3): 455 - 460.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
S M Aronica, A Dozier, P Fanti, and M Nazareth
Altered bone marrow cell sensitivity in the lupus-prone NZB/W mouse: regulation of CFU-GM colony formation by estrogen, tamoxifen and thrombopoietin
Lupus, May 1, 2000; 9(4): 271 - 277.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
J. A. Martiney, B. Sherry, C. N. Metz, M. Espinoza, A. S. Ferrer, T. Calandra, H. E. Broxmeyer, and R. Bucala
Macrophage Migration Inhibitory Factor Release by Macrophages after Ingestion of Plasmodium chabaudi-Infected Erythrocytes: Possible Role in the Pathogenesis of Malarial Anemia
Infect. Immun., April 1, 2000; 68(4): 2259 - 2267.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Clemons, A. Watson, A. Howell, J. Chang, C. Heyworth, B. Lord, N. Testa, T. M. Dexter, and G. Margison
Macrophage Inflammatory Protein 1{{alpha}} Attenuates the Toxic Effects of Temozolomide in Human Bone Marrow Granulocyte- Macrophage Colony-forming Cells
Clin. Cancer Res., March 1, 2000; 6(3): 966 - 970.
[Abstract] [Full Text]


Home page
BloodHome page
S. E. J. Cotterell, C. R. Engwerda, and P. M. Kaye
Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-alpha
Blood, March 1, 2000; 95(5): 1642 - 1651.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. E. Broxmeyer, S. Cooper, G. Hangoc, J.-L. Gao, and P. M. Murphy
Dominant Myelopoietic Effector Functions Mediated by Chemokine Receptor CCR1
J. Exp. Med., June 21, 1999; 189(12): 1987 - 1992.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. Nicholls, G. Lucas, G. J. Graham, N. H. Russell, R. Mottram, A. D. Whetton, and A.-M. Buckle
Macrophage-Inflammatory Protein-1{alpha} Receptor Expression on Normal and Chronic Myeloid Leukemia CD34+ Cells
J. Immunol., May 15, 1999; 162(10): 6191 - 6199.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Dürig, N. G. Testa, and C. M. Heyworth
Distinct Biological Effects of Macrophage Inflammatory Protein-1{alpha} and Stroma-Derived Factor-1{alpha} on CD34+ Hemopoietic Cells
Stem Cells, March 1, 1999; 17(2): 62 - 71.
[Abstract] [Full Text]


Home page
BloodHome page
S. Reid, A. Ritchie, L. Boring, J. Gosling, S. Cooper, G. Hangoc, I. F. Charo, and H. E. Broxmeyer
Enhanced Myeloid Progenitor Cell Cycling and Apoptosis in Mice Lacking the Chemokine Receptor, CCR2
Blood, March 1, 1999; 93(5): 1524 - 1533.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Durig, E. A. de Wynter, C. Kasper, M. A. Cross, J. Chang, N. G. Testa, and C. M. Heyworth
Expression of Macrophage Inflammatory Protein-1alpha Receptors in Human CD34+ Hematopoietic Cells and Their Modulation by Tumor Necrosis Factor-alpha and Interferon-gamma
Blood, November 1, 1998; 92(9): 3073 - 3081.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.D. Cashman, C.J. Eaves, A.H. Sarris, and A.C. Eaves
MCP-1, not MIP-1alpha , Is the Endogenous Chemokine That Cooperates With TGF-beta to Inhibit the Cycling of Primitive Normal but not Leukemic (CML) Progenitors in Long-Term Human Marrow Cultures
Blood, October 1, 1998; 92(7): 2338 - 2344.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yanagihara, E. Komura, J. Nagafune, H. Watarai, and Y. Yamaguchi
EBI1/CCR7 Is a New Member of Dendritic Cell Chemokine Receptor That Is Up-Regulated upon Maturation
J. Immunol., September 15, 1998; 161(6): 3096 - 3102.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E.A. de Wynter, J. Durig, M.A. Cross, C.M. Heyworth, and N.G. Testa
Differential Response of CD34+ Cells Isolated from Cord Blood and Bone Marrow to MIP-1{alpha} and the Expression of MIP-1{alpha} Receptors on These Immature Cells
Stem Cells, September 1, 1998; 16(5): 349 - 356.
[Abstract] [Full Text]


Home page
BloodHome page
M. Ohta, T. Sakai, Y. Saga, S.-i. Aizawa, and M. Saito
Suppression of Hematopoietic Activity in Tenascin-C-Deficient Mice
Blood, June 1, 1998; 91(11): 4074 - 4083.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. S. Haneline, H. E. Broxmeyer, S. Cooper, G. Hangoc, M. Carreau, M. Buchwald, and D. W. Clapp
Multiple Inhibitory Cytokines Induce Deregulated Progenitor Growth and Apoptosis in Hematopoietic Cells From Fac-/- Mice
Blood, June 1, 1998; 91(11): 4092 - 4098.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B.-S. Youn, S. M. Zhang, H. E. Broxmeyer, S. Cooper, K. Antol, M. Fraser Jr, and B. S. Kwon
Characterization of CKbeta 8 and CKbeta 8-1: Two Alternatively Spliced Forms of Human beta -Chemokine, Chemoattractants for Neutrophils, Monocytes, and Lymphocytes, and Potent Agonists at CC Chemokine Receptor 1 
Blood, May 1, 1998; 91(9): 3118 - 3126.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. D. Krathwohl, R. Hromas, D. R. Brown, H. E. Broxmeyer, and K. H. Fife
Functional characterization of the C---C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2
PNAS, September 2, 1997; 94(18): 9875 - 9880.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nagira, T. Imai, K. Hieshima, J. Kusuda, M. Ridanpaa, S. Takagi, M. Nishimura, M. Kakizaki, H. Nomiyama, and O. Yoshie
Molecular Cloning of a Novel Human CC Chemokine Secondary Lymphoid-Tissue Chemokine That Is a Potent Chemoattractant for Lymphocytes and Mapped to Chromosome 9p13
J. Biol. Chem., August 1, 1997; 272(31): 19518 - 19524.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. J. Rollins
Chemokines
Blood, August 1, 1997; 90(3): 909 - 928.
[Full Text] [PDF]


Home page
JEMHome page
J.-L. Gao, T. A. Wynn, Y. Chang, E. J. Lee, H. E. Broxmeyer, S. Cooper, H. L. Tiffany, H. Westphal, J. Kwon-Chung, and P. M. Murphy
Impaired Host Defense, Hematopoiesis, Granulomatous Inflammation and Type 1-Type 2 Cytokine Balance in Mice Lacking CC Chemokine Receptor 1
J. Exp. Med., June 2, 1997; 185(11): 1959 - 1968.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Yoshida, T. Imai, K. Hieshima, J. Kusuda, M. Baba, M. Kitaura, M. Nishimura, M. Kakizaki, H. Nomiyama, and O. Yoshie
Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7
J. Biol. Chem., May 23, 1997; 272(21): 13803 - 13809.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Hromas, P. W. Gray, D. Chantry, R. Godiska, M. Krathwohl, K. Fife, G. I. Bell, J. Takeda, S. Aronica, M. Gordon, et al.
Cloning and Characterization of Exodus, a Novel beta -Chemokine
Blood, May 1, 1997; 89(9): 3315 - 3322.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Imai, T. Yoshida, M. Baba, M. Nishimura, M. Kakizaki, and O. Yoshie
Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus Vector
J. Biol. Chem., August 30, 1996; 271(35): 21514 - 21521.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
N Basara, S Stosic-Grujicic, D Sefer, Z Ivanovic, P Antunovic, and P Milenkovic
The inhibitory effect of human macrophage inflammatory protein-1 alpha (LD78) on acute myeloid leukemia cells in vitro
Stem Cells, July 1, 1996; 14(4): 445 - 451.
[Abstract]


Home page
ScienceHome page
F. Cocchi, A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso
Identification of RANTES, MIP-1alpha, and MIP-1beta as the Major HIV-Suppressive Factors Produced by CD8+ T Cells
Science, December 15, 1995; 270(5243): 1811 - 1815.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Daly, G. J. LaRosa, S. Dolich, T. E. Maione, S. Cooper, and H. E. Broxmeyer
High Activity Suppression of Myeloid Progenitor Proliferation by Chimeric Mutants of Interleukin 8 and Platelet Factor 4
J. Biol. Chem., October 6, 1995; 270(40): 23282 - 23292.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
K Tashiro, H Tada, R Heilker, M Shirozu, T Nakano, and T Honjo
Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins
Science, July 30, 1993; 261(5121): 600 - 603.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1990 by American Society of Hematology         Online ISSN: 1528-0020